What are the biggest Alzheimer's research advances from #AAIC2026? Dr. Gil Rabinovici, director of the UCSF Alzheimer's Disease Research Center, discusses blood-based biomarkers, emerging therapies, lifestyle interventions and more in a new JAMA interview. bit.ly/4yWPiiv #AlzheimersResearch

Tau Protein Blood Tests and More From AAIC 2026

This Medical News article is an interview with neurologist Gil Rabinovici, MD, about research presented at the recent Alzheimer’s Association International Conference in London.

bit.ly

Could a brief speech sample support primary progressive aphasia (PPA) diagnosis? Researchers at the UCSF Fein Memory and Aging Center found that automated analysis of a 1-2 minute picture description accurately distinguished PPA variants and aligned with known brain and pathology patterns.

#DADM Call for Papers Open TODAY! Topic: Biomarkers for Alzheimer's disease co-pathologies ⏰Deadline: March 31, 2027 Submit today! alz-journals.onlinelibrary.wiley.com/hub/journal/...

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Submission Start: 3 August, 2026Submission Deadline: 31 March, 2027

alz-journals.onlinelibrary.wiley.com

Our new paper in @jamaneurology.com shows that automated analysis of just 1–2 minutes of speech can accurately distinguish primary progressive aphasia variants and reflects their underlying anatomy & pathology, with potential as a practical, interpretable tool to aid diagnosis and disease monitoring

New in Nature Aging: a roadmap for agentic AI to scale specialist-level diagnosis and care in Alzheimer's and related dementias through a continuously learning healthcare system, timely as disease-modifying therapies emerge. rdcu.be/fwPAP #AgenticAI #Alzheimers

Agentic AI for scaling diagnosis and care in neurodegenerative disease

Nature Aging - In this Perspective, the authors envision that agentic AI systems may in the future support clinical workflows for neurodegenerative disease diagnosis and care. They propose a system...

rdcu.be

This work also reflects part of the clinical-translational vision for our UCSF NeuroAI Lab and what we're building at the @ucsfmac.bsky.social We are hiring: neuroailab.ucsf.edu/careers/ @ucsf-bchsi.bsky.social @ucjointcph.bsky.social @ucsfci2.bsky.social #Postdoc #DataScience #ClinicalResearch

A new Nature Aging Perspective from UCSF and collaborators envisions a continuously learning AI system that supports clinicians while maintaining human oversight, patient safety, and transparency. go.nature.com/4bhCOrI #HealthAI #Neurology

Can FTLD-TDP and LATE-NC be reliably distinguished? Researchers at UCSF Fein Memory and Aging Center analyzed one of the largest FTLD-TDP brain bank cohorts and found that, despite important clinical and pathological overlap, the evidence supports these as distinct disease entities.

Neuropathological hallmarks of FTLD-TDP type A and LATE-NC in MFG.

Eight microscope images compare brain tissue from FTLD-TDP type A and LATE-NC. The first four panels show tissue from the middle frontal gyrus stained with H&E and TDP-43, highlighting abnormal TDP-43 protein deposits inside nerve cells and their processes. The remaining panels show a FTLD-TDP type A case with a greater burden of TDP-43 pathology in other brain regions, including the subgenual cingulate, entorhinal cortex and superior temporal gyrus. The figure illustrates that examining only the middle frontal gyrus may not reliably distinguish FTLD-TDP type A from LATE-NC.

bit.ly

How can the arts support healing in health care? A @NewsHour segment highlights how arts programs at UCSF Health are supporting patients of all ages. The story explores how the arts can complement medical care by helping ⬇️ stress, ⬆️ resilience & ⬆️ emotional well-being. Watch:

How hospitals are using the arts to help patients recover

As the impact of art on better health outcomes is being studied more and more, some hospital systems are now focusing on even the youngest of patients. Special correspondent Mike Cerre took a look at…

buff.ly

Capt. "Sully" Sullenberger has announced that he has been diagnosed with early-stage Alzheimer's disease, sharing that his physician, Gil Rabinovici, MD, of UCSF, helped him better understand the impact of the disease. We are grateful for his openness in raising awareness about Alzheimer's.

Home

UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to…

memory.ucsf.edu

Led by Adam Boxer, MD, PhD, and colleagues, UCSF is screening participants for the Alzheimer's Tau Platform (ATP) trial, the first large-scale national study to test combination therapy targeting both amyloid and tau in early or asymptomatic Alzheimer's disease.

UCSF Screens First Patients in Novel Alzheimer’s Trial

A study will test new drugs for early disease in an effort to prevent the buildup of toxic tau tangles that lead to cognitive decline.

bit.ly

"Miracle on the Hudson" pilot Capt. "Sully" Sullenberger has revealed he has early-stage Alzheimer's disease. He credits his physician, @ucsfmac.bsky.social's Dr. Gil Rabinovici, for opening his eyes to the prevalence of the disease: "We will be courageous together." https://ucsfh.org/4vt9aqn

'Sully' Sullenberger Announces Early-Stage Alzheimer's Diagnosis

Capt. Chesley "Sully" Sullenberger, the pilot celebrated for safely landing US Airways Flight 1549 on the Hudson River in 2009, has announced he has been diagno

ucsfh.org

What if we could slow Alzheimer’s before symptoms appear? A new UCSF trial is testing whether treating both amyloid and tau proteins at the earliest signs of tau buildup works better than targeting either protein alone, Dr. Adam Boxer says. https://ucsfh.org/3R8YeQS

Read highlights of the scientific advances reported this week at #AAIC26. https://bit.ly/4aXsaWL

Dementia Research Advances from AAIC 2026

The latest scientific advances included new insights into Alzheimer’s blood tests for improving diagnosis in primary care & for predicting future cognitive decline.

bit.ly

Memory loss isn't always the first sign of early-onset Alzheimer's disease. In conversation with Being Patient, Dr. Gil Rabinovici discusses how changes in executive function, language, visual processing and behavior can be early symptoms. And how biomarkers improve diagnosis.

Early-Onset Alzheimer’s: The Symptoms Beyond Memory Loss

Memory loss is not always the first sign of early-onset Alzheimer’s. Dr. Gil Rabinovici explains the lesser-known symptoms.

bit.ly

How has our understanding of Alzheimer's disease pathology evolved, and what does the emerging pathomics era mean for research? UCSF Fein Memory and Aging Center Lecture Series Monday, July 6 10–11 a.m. PT Melissa Murray, PhD Mayo Clinic, Jacksonville More information:

Edward and Pearl Fein Memory and Aging Center Lecture Series

A Brief History of Alzheimer's Disease Pathology Leading to the Pathomics Era Melissa E. Murray, PhD Professor of Neuroscience Mayo Clinic, Jacksonville Learning Objectives To recognize tau and…

bit.ly

UCSF neurologist Kristine Yaffe, MD, has been at the forefront of research into the "modifiable risks" that can protect cognition as we age. Here she shares how sleep, exercise, heart health, and vaccines may delay or prevent dementia: https://ow.ly/Fiav50ZjTiN

I’m a Neurologist. Here’s How to Protect Your Aging Brain

UCSF expert Kristine Yaffe, MD, explores how targeting modifiable risk factors—like sleep and exercise—can actively protect your aging brain.

ow.ly

How has our understanding of Alzheimer's disease pathology evolved, and what does the emerging pathomics era mean for research? UCSF Fein Memory and Aging Center Lecture Series Monday, July 6 10–11 a.m. PT Melissa Murray, PhD Mayo Clinic, Jacksonville More information:

Edward and Pearl Fein Memory and Aging Center Lecture Series

A Brief History of Alzheimer's Disease Pathology Leading to the Pathomics Era Melissa E. Murray, PhD Professor of Neuroscience Mayo Clinic, Jacksonville Learning Objectives To recognize tau and…

bit.ly

We're proud to see Virginia Sturm, PhD, featured in TIME's latest story on the science of awe. It highlights her research showing that experiencing awe can help people feel more connected to others and features her "awe walk" study. Read at

Why You Should Seek Out a Few Minutes of Awe Every Day

You don’t need to wait for an eclipse. Noticing a swirl of milk in your coffee might be enough.

bit.ly

Join the UCSF Edward and Pearl Fein Memory and Aging Center Grand Rounds for “Lost Connections: Modeling Synaptic Failure in FTD/ALS,” presented by Rita Sattler, PhD. 📅 Monday, June 29 🕙 10–11 a.m. PT 📍 Sandler Neurosciences Center & online Register:

Edward and Pearl Fein Memory and Aging Center Lecture Series

Lost Connections: Modeling Synaptic Failure in FTD/ALS Rita Sattler, PhD Professor, Department of Translational Neuroscience ‌David and Weezie Reese Chair for Neurodegeneration Research Barrow…

bit.ly

Join the UCSF Edward and Pearl Fein Memory and Aging Center Grand Rounds for “Lost Connections: Modeling Synaptic Failure in FTD/ALS,” presented by Rita Sattler, PhD. 📅 Monday, June 29 🕙 10–11 a.m. PT 📍 Sandler Neurosciences Center & online Register:

Edward and Pearl Fein Memory and Aging Center Lecture Series

Lost Connections: Modeling Synaptic Failure in FTD/ALS Rita Sattler, PhD Professor, Department of Translational Neuroscience ‌David and Weezie Reese Chair for Neurodegeneration Research Barrow…

bit.ly

Edward and Pearl Fein Memory and Aging Center Grand Rounds Join Suzanne E. Schindler, MD, PhD, of Wash U in St. Louis for a discussion of the real-world use of diagnostics and treatments for Alzheimer’s disease. Monday, June 22 | 10-11 a.m. PT Genentech Hall & online Register: bit.ly/4vU5OgK

Edward and Pearl Fein Memory and Aging Center Grand Rounds Join Suzanne E. Schindler, MD, PhD, of Wash U in St. Louis for a discussion of the real-world use of diagnostics and treatments for Alzheimer’s disease. Monday, June 22 | 10-11 a.m. PT Genentech Hall & online Register: bit.ly/4vU5OgK

Join the Global Brain Health Institute and UCSF Fein Memory and Aging Center for “Let This Be a Symphony: The Art and Impact of Co-Created Dementia Advocacy,” a special film screening and panel discussion marking GBHI’s 10th anniversary. Tuesday, May 19, 4:30 to 5:45 p.m. PT buff.ly/n5hSld8 #GBHI10

Join us for a special screening of Keys Bags Names Words: Hope in Aging and Dementia today from 4:30-6:30 p.m. PT at Rock Hall, Pottruck Auditorium, 1550 4th St., San Francisco. A panel discussion will follow as we celebrate 10 years of the Global Brain Health Institute at UCSF. #GBHI10

Edward and Pearl Fein Memory and Aging Center Lecture Series Monday, April 13, 10–11 a.m. PT Dorene M. Rentz, PsyD (Harvard Medical School), will discuss digital tools for detecting risk of cognitive decline in clinical and research settings. Register 👉 bit.ly/4vfz1n5

Join @alzassociation.bsky.social, The Rainwater Charitable Foundation and CurePSP for #Tau2026, May 14-15, 2026, in Washington, D.C., and online! Be part of the conversation as leading experts work to move tau research forward. Register now: alz.org/Tau

Tau Global Conference | Alzheimer's Association

Leading experts from academia, industry, philanthropy and government will meet to address the future of tau research. Learn more and register.

alz.org

Gallery 190 Opening Reception: Nancy Richards Farese Thursday, April 9, 4:30–6 p.m. PT Sandler Neurosciences Center, Suite 190 Remarks at 5 p.m. by Dr. Bruce Miller and the artist. Free and open to the public. bit.ly/4c20LT5 #ArtAndMemory #Neuroscience

Gallery 190 Opening Reception: Nancy Richards Farese

Join us for an afternoon reception in Gallery 190 on Thursday, April 9 to celebrate the exhibition Nancy Richards Farese: ADD|MIX|FOLD. Functioning as a visual memoir, the work looks back on the…

bit.ly

Edward and Pearl Fein Memory and Aging Center Lecture Series Monday, April 13, 10–11 a.m. PT Dorene M. Rentz, PsyD (Harvard Medical School), will discuss digital tools for detecting risk of cognitive decline in clinical and research settings. Register 👉 bit.ly/4vfz1n5

Gallery 190 Opening Reception: Nancy Richards Farese Thursday, April 9, 4:30–6 p.m. PT Sandler Neurosciences Center, Suite 190 Remarks at 5 p.m. by Dr. Bruce Miller and the artist. Free and open to the public. bit.ly/4c20LT5 #ArtAndMemory #Neuroscience

Gallery 190 Opening Reception: Nancy Richards Farese

Join us for an afternoon reception in Gallery 190 on Thursday, April 9 to celebrate the exhibition Nancy Richards Farese: ADD|MIX|FOLD. Functioning as a visual memoir, the work looks back on the…

bit.ly